Copyright Reports & Markets. All rights reserved.

Global In Vivo and In Vitro ADME Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global In Vivo and In Vitro ADME Market Size 2016-2026
    • 2.1.2 In Vivo and In Vitro ADME Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 In Vivo and In Vitro ADME Segment by Type
    • 2.2.1 Small Molecules
    • 2.2.2 Small Molecules
  • 2.3 In Vivo and In Vitro ADME Market Size by Type
    • 2.3.1 Global In Vivo and In Vitro ADME Market Size CAGR by Type
    • 2.3.2 Global In Vivo and In Vitro ADME Market Size Market Share by Type (2016-2021)
  • 2.4 In Vivo and In Vitro ADME Segment by End User
    • 2.4.1 Biopharmaceutical Companies
    • 2.4.2 Government and Academic Institutes
    • 2.4.3 Others
  • 2.5 In Vivo and In Vitro ADME Market Size by End User
    • 2.5.1 Global In Vivo and In Vitro ADME Market Size CAGR by End User
    • 2.5.2 Global In Vivo and In Vitro ADME Market Size Market Share by End User (2016-2021)

3 In Vivo and In Vitro ADME Market Size by Players

  • 3.1 In Vivo and In Vitro ADME Market Size Market Share by Players
    • 3.1.1 Global In Vivo and In Vitro ADME Revenue by Players (2019-2021E)
    • 3.1.2 Global In Vivo and In Vitro ADME Revenue Market Share by Players (2019-2021E)
  • 3.2 Global In Vivo and In Vitro ADME Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 In Vivo and In Vitro ADME by Regions

  • 4.1 In Vivo and In Vitro ADME Market Size by Regions (2016-2021)
  • 4.2 Americas In Vivo and In Vitro ADME Market Size Growth (2016-2021)
  • 4.3 APAC In Vivo and In Vitro ADME Market Size Growth (2016-2021)
  • 4.4 Europe In Vivo and In Vitro ADME Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa In Vivo and In Vitro ADME Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas In Vivo and In Vitro ADME Market Size by Country (2016-2021)
  • 5.2 Americas In Vivo and In Vitro ADME Market Size by Type (2016-2021)
  • 5.3 Americas In Vivo and In Vitro ADME Market Size by End User (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC In Vivo and In Vitro ADME Market Size by Region (2016-2021)
  • 6.2 APAC In Vivo and In Vitro ADME Market Size by Type (2016-2021)
  • 6.3 APAC In Vivo and In Vitro ADME Market Size by End User (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe In Vivo and In Vitro ADME by Country (2016-2021)
  • 7.2 Europe In Vivo and In Vitro ADME Market Size by Type (2016-2021)
  • 7.3 Europe In Vivo and In Vitro ADME Market Size by End User (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa In Vivo and In Vitro ADME by Region (2016-2021)
  • 8.2 Middle East & Africa In Vivo and In Vitro ADME Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa In Vivo and In Vitro ADME Market Size by End User (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global In Vivo and In Vitro ADME Market Forecast

  • 10.1 Global In Vivo and In Vitro ADME Forecast by Regions (2021-2026)
    • 10.1.1 Global In Vivo and In Vitro ADME Forecast by Regions (2021-2026)
    • 10.1.2 Americas In Vivo and In Vitro ADME Forecast
    • 10.1.3 APAC In Vivo and In Vitro ADME Forecast
    • 10.1.4 Europe In Vivo and In Vitro ADME Forecast
    • 10.1.5 Middle East & Africa In Vivo and In Vitro ADME Forecast
  • 10.2 Americas In Vivo and In Vitro ADME Forecast by Countries (2021-2026)
    • 10.2.1 United States In Vivo and In Vitro ADME Market Forecast
    • 10.2.2 Canada In Vivo and In Vitro ADME Market Forecast
    • 10.2.3 Mexico In Vivo and In Vitro ADME Market Forecast
    • 10.2.4 Brazil In Vivo and In Vitro ADME Market Forecast
  • 10.3 APAC In Vivo and In Vitro ADME Forecast by Region (2021-2026)
    • 10.3.1 China In Vivo and In Vitro ADME Market Forecast
    • 10.3.2 Japan In Vivo and In Vitro ADME Market Forecast
    • 10.3.3 Korea In Vivo and In Vitro ADME Market Forecast
    • 10.3.4 Southeast Asia In Vivo and In Vitro ADME Market Forecast
    • 10.3.5 India In Vivo and In Vitro ADME Market Forecast
    • 10.3.6 Australia In Vivo and In Vitro ADME Market Forecast
  • 10.4 Europe In Vivo and In Vitro ADME Forecast by Country (2021-2026)
    • 10.4.1 Germany In Vivo and In Vitro ADME Market Forecast
    • 10.4.2 France In Vivo and In Vitro ADME Market Forecast
    • 10.4.3 UK In Vivo and In Vitro ADME Market Forecast
    • 10.4.4 Italy In Vivo and In Vitro ADME Market Forecast
    • 10.4.5 Russia In Vivo and In Vitro ADME Market Forecast
  • 10.5 Middle East & Africa In Vivo and In Vitro ADME Forecast by Region (2021-2026)
    • 10.5.1 Egypt In Vivo and In Vitro ADME Market Forecast
    • 10.5.2 South Africa In Vivo and In Vitro ADME Market Forecast
    • 10.5.3 Israel In Vivo and In Vitro ADME Market Forecast
    • 10.5.4 Turkey In Vivo and In Vitro ADME Market Forecast
    • 10.5.5 GCC Countries In Vivo and In Vitro ADME Market Forecast
  • 10.6 Global In Vivo and In Vitro ADME Forecast by Type (2021-2026)
  • 10.7 Global In Vivo and In Vitro ADME Forecast by End User (2021-2026)

11 Key Players Analysis

  • 11.1 Charles River
    • 11.1.1 Charles River Company Information
    • 11.1.2 Charles River In Vivo and In Vitro ADME Product Offered
    • 11.1.3 Charles River In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Charles River Main Business Overview
    • 11.1.5 Charles River Latest Developments
  • 11.2 Labcorp
    • 11.2.1 Labcorp Company Information
    • 11.2.2 Labcorp In Vivo and In Vitro ADME Product Offered
    • 11.2.3 Labcorp In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 Labcorp Main Business Overview
    • 11.2.5 Labcorp Latest Developments
  • 11.3 ICON
    • 11.3.1 ICON Company Information
    • 11.3.2 ICON In Vivo and In Vitro ADME Product Offered
    • 11.3.3 ICON In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 ICON Main Business Overview
    • 11.3.5 ICON Latest Developments
  • 11.4 Syneos Health
    • 11.4.1 Syneos Health Company Information
    • 11.4.2 Syneos Health In Vivo and In Vitro ADME Product Offered
    • 11.4.3 Syneos Health In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Syneos Health Main Business Overview
    • 11.4.5 Syneos Health Latest Developments
  • 11.5 Envigo
    • 11.5.1 Envigo Company Information
    • 11.5.2 Envigo In Vivo and In Vitro ADME Product Offered
    • 11.5.3 Envigo In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 Envigo Main Business Overview
    • 11.5.5 Envigo Latest Developments
  • 11.6 Curia
    • 11.6.1 Curia Company Information
    • 11.6.2 Curia In Vivo and In Vitro ADME Product Offered
    • 11.6.3 Curia In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Curia Main Business Overview
    • 11.6.5 Curia Latest Developments
  • 11.7 Evotec
    • 11.7.1 Evotec Company Information
    • 11.7.2 Evotec In Vivo and In Vitro ADME Product Offered
    • 11.7.3 Evotec In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Evotec Main Business Overview
    • 11.7.5 Evotec Latest Developments
  • 11.8 Bioduro-Sundia
    • 11.8.1 Bioduro-Sundia Company Information
    • 11.8.2 Bioduro-Sundia In Vivo and In Vitro ADME Product Offered
    • 11.8.3 Bioduro-Sundia In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 Bioduro-Sundia Main Business Overview
    • 11.8.5 Bioduro-Sundia Latest Developments
  • 11.9 Lonza
    • 11.9.1 Lonza Company Information
    • 11.9.2 Lonza In Vivo and In Vitro ADME Product Offered
    • 11.9.3 Lonza In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Lonza Main Business Overview
    • 11.9.5 Lonza Latest Developments
  • 11.10 WuXi AppTec
    • 11.10.1 WuXi AppTec Company Information
    • 11.10.2 WuXi AppTec In Vivo and In Vitro ADME Product Offered
    • 11.10.3 WuXi AppTec In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 WuXi AppTec Main Business Overview
    • 11.10.5 WuXi AppTec Latest Developments

11. IQVIA

  • 11.11.1 IQVIA Company Information
  • 11.11.2 IQVIA In Vivo and In Vitro ADME Product Offered
  • 11.11.3 IQVIA In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 IQVIA Main Business Overview
  • 11.11.5 IQVIA Latest Developments
  • 11.12 Tecan Group
    • 11.12.1 Tecan Group Company Information
    • 11.12.2 Tecan Group In Vivo and In Vitro ADME Product Offered
    • 11.12.3 Tecan Group In Vivo and In Vitro ADME Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Tecan Group Main Business Overview
    • 11.12.5 Tecan Group Latest Developments
  • 11.13 Pharmaron
    • 11.13.1 Pharmaron Company Information

    • According to this latest study, the 2021 growth of In Vivo and In Vitro ADME will have significant change from previous year. By the most conservative estimates of global In Vivo and In Vitro ADME market size (most likely outcome) will be a year-over-year revenue growth rate of % in 2021, from US$ million in 2020. Over the next five years the In Vivo and In Vitro ADME market will register a % CAGR in terms of revenue, the global market size will reach US$ million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of In Vivo and In Vitro ADME market by product type, application, key players and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Small Molecules
    Biologics

    Segmentation by end user: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Biopharmaceutical Companies
    Government and Academic Institutes
    Others

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Charles River
    Labcorp
    ICON
    Syneos Health
    Envigo
    Curia
    Evotec
    Bioduro-Sundia
    Lonza
    WuXi AppTec
    IQVIA
    Tecan Group
    Pharmaron
    Shanghai Medicilon
    ChemPartner
    Joinn Laboratories
    RTI International
    Eurofins Scientific
    Aragen Life Sciences
    Sai Life Sciences
    Buy now